SCHEMBL22955779

SCHEMBL22955779

c1ccc(-c2cc(-c3cccc(-c4cccc(-c5c6ccccc6c(-c6cccc(-c7ccncc7)c6)c6ccccc56)c4)c3)c(-c3ccccc3)c(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 3/20 0.48
PIK3CA P42336 1/20 0.46
NOTUM Q6P988 1/20 0.46
MKNK1 Q9BUB5 1/20 0.43
PRKCI P41743 1/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 1/20 0.39
MAPK13 O15264 1/20 0.39
GCGR P47871 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
KIF11 P52732 1/20 0.38
CHEK1 O14757 2/20 0.38
KDR P35968 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21240010 1.00 IMPDH2 (0.48) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL30386196 1.00 IMPDH2 (0.48) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL22956101 0.98 IMPDH2 (0.50) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL22955781 0.98 IMPDH2 (0.46) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL22955778 0.97 IMPDH2 (0.51) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL22955399 0.97 IMPDH2 (0.48) IMPDH2PIK3CANOTUMMKNK1PRKCI
SCHEMBL22955396 0.97 NOTUM (0.44) IMPDH2PIK3CANOTUMMKNK1MAPK1
SCHEMBL22955395 0.91 IMPDH2 (0.53) IMPDH2PIK3CANOTUMMKNK1MAPK1
SCHEMBL22955780 0.91 IMPDH2 (0.53) IMPDH2PIK3CANOTUMMKNK1MAPK1
SCHEMBL22956090 0.91 NOTUM (0.56) IMPDH2PIK3CANOTUMMKNK1PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036230-A1 Organic Material for an Electronic Optoelectronic Device and Electronic Device Comprising the Organic Material NOVALED GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036230-A1 Organic Material for an Electronic Optoelectronic Device and Electronic Device Comprising the Organic Material OCIAD1, OCIAD2, OR10J3 IMPDH2 1257/4885PIK3CA 3360/4885NOTUM 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.